Use of complementary medicines by cardiac surgery patients; undisclosed and undetected

Heart Lung and Circulation

Volumn 20, Issue 5, 2011, Pages 305-311

  Braun, Lesley A ^a,b   Cohen, Marc ^c  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c RMIT UNIVERSITY   (Australia)

Author keywords

Communication; Complementary medicines; Herb drug interactions; Safety; Surgery

Indexed keywords

ACCESS TO INFORMATION; AGED; ALTERNATIVE MEDICINE; ARTICLE; CARDIAC PATIENT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOCTOR PATIENT RELATION; ELECTIVE SURGERY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HERB DRUG INTERACTION; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT SAFETY; PERIOPERATIVE PERIOD; PRESCRIPTION; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR DISEASES; COMMUNICATION; COMPLEMENTARY THERAPIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; QUESTIONNAIRES; VICTORIA;

EID: 79954807070     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2011.01.013     Document Type: Article

References (53)

1. Eisenberg D.M., Davis R.B., Ettner S.L., Appel S., Wilkey S., Van R.M., et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998, 280(18):1569-1575.
2. Xue C.C., Zhang A.L., Lin V., Da C.C., Story D.F. Complementary and alternative medicine use in Australia: a national population-based survey. J Altern Complement Med 2007, 13(6):643-650.
3. Gavin J.A., Boon H. CAM in Canada: places, practices, research. Complement Ther Clin Pract 2005, 11(1):21-27.
4. McFarland B., Bigelow D., Zani B., Newsom J., Kaplan M. Complementary and alternative medicine use in Canada and the United States. Am J Public Health 2002, 92(10):1616-1618.
5. Zollman C., Vickers A. ABC of complementary medicine. Users and practitioners of complementary medicine. BMJ 1999, 319(7213):836-838.
6. MacLennan A.H., Myers S.P., Taylor A.W. The continuing use of complementary and alternative medicine in South Australia: costs and beliefs in 2004. Med J Aust 2006, 184(1):27-31.
7. Robinson A., McGrail M.R. Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med 2004, 12(2-3):90-98.
8. Valli G., Giardina E.G. Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects. J Am Coll Cardiol 2002, 39(7):1083-1095.
9. Miller K.L., Liebowitz R.S., Newby L.K. Complementary and alternative medicine in cardiovascular disease: a review of biologically based approaches. Am Heart J 2004, 147(3):401-411.
10. Harper C.R., Jacobson T.A. Usefulness of omega-3 fatty acids and the prevention of coronary heart disease. Am J Cardiol 2005, 96(11):1521-1529.
11. Pittler M.H., Schmidt K., Ernst E. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials. Am J Med 2003, 114(8):665-674.
12. Norred C.L., Finlayson C.A. Hemorrhage after the preoperative use of complementary and alternative medicines. AANA J 2000, 68(3):217-220.
13. Norred C.L., Brinker F. Potential coagulation effects of preoperative complementary and alternative medicines. Altern Ther Health Med 2001, 7(6):58-67.
14. Ang-Lee M.K., Moss J., Yuan C.S. Herbal medicines and perioperative care. JAMA 2001, 286(2):208-216.
15. Raduege K.M., Kleshinski J.F., Ryckman J.V., Tetzlaff J.E. Anesthetic considerations of the herbal, kava. J Clin Anesth 2004, 16(4):305-311.
16. Adusumilli P.S., Ben Porat L., Pereira M., Roesler D., Leitman I.M. The prevalence and predictors of herbal medicine use in surgical patients. J Am Coll Surg 2004, 198(4):583-590.
17. Kaye A.D., Clarke R.C., Sabar R., Vig S., Dhawan K.P., Hofbauer R., et al. Herbal medicines: current trends in anesthesiology practice-a hospital survey. J Clin Anesth 2000, 12(6):468-471.
18. Leung J.M., Dzankic S., Manku K., Yuan S. The prevalence and predictors of the use of alternative medicine in presurgical patients in five California hospitals. Anesth Analg 2001, 93(4):1062-1068.
19. Norred C.L. Complementary and alternative medicine use by surgical patients. AORN J 2002, 76(6):1013-1021.
20. Grauer R.P., Thomas R.D., Tronson M.D., Heard G.C., Diacon M. Preoperative use of herbal medicines and vitamin supplements. Anaesth Intensive Care 2004, 32(2):173-177. [4-1-2004. Health and medical complete. Ref Type: Abstract].
21. Yeh G.Y., Davis R.B., Phillips R.S. Use of complementary therapies in patients with cardiovascular disease. Am J Cardiol 2006, 98(5):673-680.
22. Braun L., Cohen M. Herbs and natural supplements-an evidence based guide 2010, Elsevier, Sydney. 3rd ed.
23. Bernd A., Simon S., Ramirez B.A., Kippenberger S., Diaz A.J., Miquel J., et al. Phototoxic effects of Hypericum extract in cultures of human keratinocytes compared with those of psoralen. Photochem Photobiol 1999, 69(2):218-221.
24. Sabar R., Kaye A.D., Frost E.A. Perioperative considerations for the patient taking herbal medicines. Heart Dis 2001, 3(2):87-96.
25. Briggs D.R. The regulation of herbal medicines in Australia. Toxicology 2002, 181-182:565-570.
26. Saldana M.D., Zetzl C., Mohamed R.S., Brunner G. Extraction of methylxanthines from guarana seeds, mate leaves, and cocoa beans using supercritical carbon dioxide and ethanol. J Agric Food Chem 2002, 50(17):4820-4826.
27. Aruna D., Naidu M.U. Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects. Br J Clin Pharmacol 2007, 63(3):333-338.
28. Bal Dit S.C., Caplain H., Drouet L. No alteration in platelet function or coagulation induced by EGb761 in a controlled study. Clin Lab Haematol 2003, 25(4):251-253.
29. Beckert B.W., Concannon M.J., Henry S.L., Smith D.S., Puckett C.L. The effect of herbal medicines on platelet function: an in vivo experiment and review of the literature. Plast Reconstr Surg 2007, 120(7):2044-2050.
30. Engelsen J., Nielsen J.D., Hansen K.F. Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial. Ugeskr Laeger 2003, 165(18):1868-1871.
31. Gardner C.D., Zehnder J.L., Rigby A.J., Nicholus J.R., Farquhar J.W. Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial. Blood Coagul Fibrinolysis 2007, 18(8):787-793.
32. Jiang X., Williams K.M., Liauw W.S., Ammit A.J., Roufogalis B.D., Duke C.C., et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2005, 59(4):425-432.
33. Kohler S., Funk P., Kieser M. Influence of a 7-day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation: a randomized, placebo-controlled, double-blind study in healthy volunteers. Blood Coagul Fibrinolysis 2004, 15(4):303-309.
34. Wolf H.R. Does Ginkgo biloba special extract EGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500mg daily?. Drugs R D 2006, 7(3):163-172.
35. Carlson J.J., Farquhar J.W., DiNucci E., Ausserer L., Zehnder J., Miller D., et al. Safety and efficacy of a ginkgo biloba-containing dietary supplement on cognitive function, quality of life, and platelet function in healthy, cognitively intact older adults. J Am Diet Assoc 2007, 107(3):422-432.
36. Lovera J., Bagert B., Smoot K., Morris C.D., Frank R., Bogardus K., et al. Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial. Mult Scler 2007, 13(3):376-385.
37. Lau A.J., Chang T.K. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols. Drug Metab Dispos 2009, 37(9):1931-1937.
38. Lei H.P., Wang G., Wang L.S., Ou-yang D.S., Chen H., Li Q., et al. Lack of effect of Ginkgo biloba on voriconazole pharmacokinetics in Chinese volunteers identified as CYP2C19 poor and extensive metabolizers. Ann Pharmacother 2009, 43(4):726-731
39. Robertson S.M., Davey R.T., Voell J., Formentini E., Alfaro R.M., Penzak S.R. Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects. Curr Med Res Opin 2008, 24(2):591-599.
40. Greenblatt D.J., von Moltke L.L., Luo Y., Perloff E.S., Horan K.A., Bruce A., et al. Ginkgo biloba does not alter clearance of flurbiprofen, a cytochrome P450-2C9 substrate. J Clin Pharmacol 2006, 46(2):214-221.
41. Gurley B.J., Gardner S.F., Hubbard M.A., Williams D.K., Gentry W.B., Cui Y., et al. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging 2005, 22(6):525-539.
42. Barrett B. Medicinal properties of Echinacea: a critical review. Phytomedicine 2003, 10(1):66-86.
43. Freeman C., Spelman K. A critical evaluation of drug interactions with Echinacea spp. Mol Nutr Food Res 2008, 52(7):789-798.
44. Modarai M., Gertsch J., Suter A., Heinrich M., Kortenkamp A. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content. J Pharm Pharmacol 2007, 59(4):567-573.
45. Penzak S.R., Robertson S.M., Hunt J.D., Chairez C., Malati C.Y., Alfaro R.M., et al. Echinacea purpurea significantly induces cytochrome P450 3A activity but does not alter lopinavir-ritonavir exposure in healthy subjects. Pharmacotherapy 2010, 30(8):797-805.
46. Davis E.M., Packard K.A., Hilleman D.E. Pharmacologic prophylaxis of postoperative atrial fibrillation in patients undergoing cardiac surgery: beyond beta-blockers. Pharmacotherapy 2010, 30(7). 749, 274e-749, 318e.
47. Harris W.S. Expert opinion: omega-3 fatty acids and bleeding-cause for concern?. Am J Cardiol 2007, 99(6A):44C-46C.
48. Poolsup N., Suthisisang C., Channark P., Kittikulsuth W. Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials. Ann Pharmacother 2005, 39(6):1080-1087.
49. Knudsen J.F., Sokol G.H. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database. Pharmacotherapy 2008, 28(4):540-548.
50. Cutshall S.M., Wentworth L.J., Engen D., Sundt T.M., Kelly R.F., Bauer B.A. Effect of massage therapy on pain, anxiety, and tension in cardiac surgical patients: a pilot study. Complement Ther Clin Pract 2010, 16(2):92-95.
51. Bauer B.A., Cutshall S.M., Wentworth L.J., Engen D., Messner P.K., Wood C.M., et al. Effect of massage therapy on pain, anxiety, and tension after cardiac surgery: a randomized study. Complement Ther Clin Pract 2010, 16(2):70-75.
52. Albert N.M., Gillinov A.M., Lytle B.W., Feng J., Cwynar R., Blackstone E.H. A randomized trial of massage therapy after heart surgery. Heart Lung 2009, 38(6):480-490.
53. Braun L.A., Tiralongo E., Wilkinson J.M., Spitzer O., Bailey M., Poole S., et al. Perceptions, use and attitudes of pharmacy customers on complementary medicines and pharmacy practice. BMC Complement Altern Med 2010, 10:38.